<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0005">
 <label>Tabla 1</label>
 <caption>
  <p>Algunas guías internacionales y nacionales de interés para profesionales sobre el tratamiento y la asistencia sanitaria a pacientes con cáncer durante la pandemia de COVID-19</p>
 </caption>
 <alt-text id="at1">Tabla 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Título de la guía</th>
    <th align="left">Sociedad Científica</th>
    <th align="left">Tipo de cáncer</th>
    <th align="left">Fuente</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="4" align="left">
     <italic>
      <bold>Ámbito internacional</bold>
     </italic>
    </td>
   </tr>
   <tr>
    <td align="left">
     <italic>Cancer patient management during the COVID-19 pandemic.</italic>
    </td>
    <td align="left">
     <italic>European Society for Medical Oncology</italic> (ESMO)
    </td>
    <td align="left">Varios</td>
    <td align="left">https://www.esmo.org/guidelines</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Management of cancer surgery cases during the COVID-19 pandemic: Considerations</italic>.
    </td>
    <td align="left">
     <italic>Society for Surgical Oncology</italic> (SSO)
    </td>
    <td align="left">Varios</td>
    <td align="left">https://doi.org/10.1245/s10434-020-08461-2</td>
   </tr>
   <tr>
    <td align="left">
     <italic>COVID-19 rapid guideline: delivery of systemic anticancer treatments</italic>.
    </td>
    <td align="left">
     <italic>National Institute for Health and Care Excellence</italic> (NICE)
    </td>
    <td align="left">Varios</td>
    <td align="left">https://www.nice.org.uk/guidance</td>
   </tr>
   <tr>
    <td align="left">
     <italic>COVID-19 rapid guideline: delivery of radiotherapy</italic>
    </td>
    <td align="left">
     <italic>National Institute for Health and Care Excellence</italic> (NICE)
    </td>
    <td align="left">Varios</td>
    <td align="left">https://www.nice.org.uk/guidance</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement</italic>.
    </td>
    <td align="left">
     <italic>European Society for</italic>
     <break/>
     <italic>Radiotherapy and Oncology (ESTRO), American Society for Radiation Oncology</italic>
     <break/>
     <italic>(ASTRO)</italic>
    </td>
    <td align="left">Pulmón</td>
    <td align="left">https://doi.org/10.1016/j.radonc.2020.04.001</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Practice recommendations for risk-adapted head and neck cancer radiotherapy during</italic>
     <break/>
     <italic>the COVID-19 pandemic: an ASTRO-ESTRO consensus statement</italic>.
    </td>
    <td align="left">
     <italic>European Society for</italic>
     <break/>
     <italic>Radiotherapy and Oncology (ESTRO), American Society for Radiation Oncology</italic>
     <break/>
     <italic>(ASTRO)</italic>
    </td>
    <td align="left">Cabeza y cuello</td>
    <td align="left">https://doi.org/10.1016/j.ijrobp.2020.04.016</td>
   </tr>
   <tr>
    <td align="left">
     <italic>ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic</italic>.
    </td>
    <td align="left">
     <italic>International Lymphoma Radiation Oncology Group</italic> (ILROG)
    </td>
    <td align="left">Neoplasias hematológicas</td>
    <td align="left">https://doi.org/10.1182/blood.2020006028</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Coronavirus disease COVID-19: EBMT recommendations.</italic>
    </td>
    <td align="left">
     <italic>European Society for Blood and Marrow Transplantation (EBMT)</italic>
    </td>
    <td align="left">Neoplasias hematológicas</td>
    <td align="left">https://www.ebmt.org/</td>
   </tr>
   <tr>
    <td align="left">
     <italic>International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic</italic>.
    </td>
    <td align="left">Grupo internacional de expertos</td>
    <td align="left">Mama</td>
    <td align="left">https://doi.org/10.1016/j.clon.2020.03.006</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Recommendations for prioritization, treatment and triage of breast cancer patients during the COVID-19 pandemic.</italic>
    </td>
    <td align="left">
     <italic>The COVID-19 Pandemic Breast Cancer Consortium</italic>
    </td>
    <td align="left">Mama</td>
    <td align="left">https://www.breastsurgeons.org/</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Prostate cancer radiation therapy recommendations in response to COVID-19.</italic>
    </td>
    <td align="left">Grupo internacional de expertos</td>
    <td align="left">Próstata</td>
    <td align="left">https://doi.org/10.1016/j.adro.2020.03.010</td>
   </tr>
   <tr>
    <td align="left">
     <italic>International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic.</italic>
    </td>
    <td align="left">Grupo internacional de expertos</td>
    <td align="left">Rectal</td>
    <td align="left">https://doi.org/10.1016/j.radonc.2020.03.039</td>
   </tr>
   <tr>
    <td align="left">
     <italic>Recommendations on the use of radiation therapy in managing</italic>
     <italic>patients with gastrointestinal malignancies in the era of COVID-19.</italic>
    </td>
    <td align="left">Grupo internacional de expertos</td>
    <td align="left">Gastrointestinal</td>
    <td align="left">https://doi.org/10.1016/j.radonc.2020.04.010</td>
   </tr>
   <tr>
    <td colspan="4" align="left">  </td>
   </tr>
   <tr>
    <td colspan="4" align="left">
     <italic>
      <bold>Ámbito nacional</bold>
     </italic>
    </td>
   </tr>
   <tr>
    <td align="left">Recomendaciones sobre la infección por SARS-COV-2 para profesionales sanitarios implicados en el tratamiento de pacientes oncológicos.</td>
    <td align="left">Sociedad Española de Oncología Médica (SEOM)</td>
    <td align="left">Varios</td>
    <td align="left">https://seom.org/</td>
   </tr>
   <tr>
    <td align="left">Recomendaciones éticas en la toma de decisiones con pacientes oncológicos durante la epidemia de COVID-19.</td>
    <td align="left">Sociedad Española de Oncología Médica (SEOM)</td>
    <td align="left">Varios</td>
    <td align="left">https://seom.org/</td>
   </tr>
   <tr>
    <td align="left">Recomendaciones para el manejo, prevención y control de COVID-19 en los servicios de oncología radioterápica.</td>
    <td align="left">Sociedad Española de Oncología Radioterápica (SEOR)</td>
    <td align="left">Varios</td>
    <td align="left">http://www.seor.es/</td>
   </tr>
   <tr>
    <td align="left">Recomendaciones para el manejo, prevención y control de COVID-19 en los hospitales de día onco-hematológicos y servicios de oncología radioterápica.</td>
    <td align="left">Sociedad Española de Oncología Médica (SEOM), Sociedad Española de Oncología Radioterápica (SEOR)</td>
    <td align="left">Varios</td>
    <td align="left">http://www.seor.es/</td>
   </tr>
   <tr>
    <td align="left">Guía de actuación para personas con condiciones de salud crónicas y personas mayores en situación de confinamiento. Estado de alarma por COVID-19.</td>
    <td align="left">Ministerio de Sanidad, España</td>
    <td align="left">Varios.</td>
    <td align="left">https://www.mscbs.gob.es/</td>
   </tr>
   <tr>
    <td align="left">Documento GEICAM sobre el manejo del paciente con cáncer de mama en la situación de pandemia de COVID-19 en España.</td>
    <td align="left">Grupo GEICAM de Investigación en Cáncer de Mama</td>
    <td align="left">Mama</td>
    <td align="left">https://www.geicam.org/</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
